Skip to main content
. 2013 Sep 26;19(3):276–282. doi: 10.1177/159101991301900303

Table 2.

Summary of risk factors and outcomes of patients in the SES/BES group who received a SES or a BES.

Variables SES
(n = 21)
BES
(n = 23)
Total
(n = 44)
p-value

Gender (male) 17 (81%) 17 (74%) 34 0.724

Age (> 65) 5 (24%) 6 (26%) 11 0.862

Symptom onset (≤2 days) 2 (9%) 0 (0%) 2 0.222

Initial NIHSS (≥4) 5 (24%) 3 (13%) 8 0.448

Presenting
symptom pattern
Stroke 14 (66%) 16 (70%) 30 0.837

TIA 7 (33%) 7 (30%) 14

Risk factors Hypertension 18 (86%) 15 (65%) 33 0.117

Diabetes mellitus 7 (33%) 11 (48%) 18 0.388

Hyperlipidaemia 12 (57%) 8 (34%) 20 0.137

Smoking 7 (33%) 6 (26%) 13 0.599

Cardiac disease 5 (24%) 1 (4%) 6 0.088

Previous stroke 3 (14%) 7 (30%) 10 0.287

Location Intracranial ICA 0 (0%) 10 (43%) 10 0.001

M1 17 (81%) 5 (22%) 22 < 0.001

Intracranial VA 3 (14%) 7 (30%) 10 0.287

Basilar artery 1 (5%) 1 (4%) 2 1.000

Adverse event in 6 m 1 (5%) 0 (0%) 1 0.477

mRS (≤2) at 6 m 21 (100%) 23 (100%) 44

Residual stenosis 4-47(32) 0-47(18) 0-47(25) < 0.001

Restenosis 4/9 (44%) 1/10 (10%) 5/19 0.327

SES = self-expandable stent, BES = balloon-expandable stent, NIHSS = National Institutes of Health Stroke Scale, TIA = transient ischemic
attach, ICA = internal carotid artery, VA = vertebral artery, mRS = modified Rankin Scale, m = months.